NCT03416127View on ClinicalTrials.gov

Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 30, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Propolis

Propolis capsules, 300 mg, two times per day before break-fast and dinner during 12 weeks.

DRUG

Metformin

Metformin capsules, 850 mg, two times per day before break-fast and dinner during 12 weeks.

DRUG

Placebo

Calcined magnesium, two times per day before break-fast and dinner during 12 weeks.

Trial Locations (1)

44340

Intstituto de Terapeútica Experimental y Clínica. Centro Universitario de Ciencias de la Salud. Universidad de Guadalajara, Guadalajara

All Listed Sponsors
lead

University of Guadalajara

OTHER

NCT03416127 - Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter